71 related articles for article (PubMed ID: 10063871)
1. Pulmonary injury from proton and conventional radiotherapy as revealed by CT.
Bush DA; Dunbar RD; Bonnet R; Slater JD; Cheek GA; Slater JM
AJR Am J Roentgenol; 1999 Mar; 172(3):735-9. PubMed ID: 10063871
[TBL] [Abstract][Full Text] [Related]
2. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer.
Gridley DS; Bonnet RB; Bush DA; Franke C; Cheek GA; Slater JD; Slater JM
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):759-66. PubMed ID: 15465192
[TBL] [Abstract][Full Text] [Related]
3. Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer.
Vogelius IR; Westerly DC; Aznar MC; Cannon GM; Korreman SS; Mackie TR; Mehta MP; Bentzen SM
Acta Oncol; 2011 Aug; 50(6):772-6. PubMed ID: 21767173
[TBL] [Abstract][Full Text] [Related]
4. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
[TBL] [Abstract][Full Text] [Related]
5. Computed tomography appearance of early radiation injury to the lung: correlation with clinical and dosimetric factors.
Jenkins P; Welsh A
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):97-103. PubMed ID: 21543163
[TBL] [Abstract][Full Text] [Related]
6. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers?
Kimura T; Matsuura K; Murakami Y; Hashimoto Y; Kenjo M; Kaneyasu Y; Wadasaki K; Hirokawa Y; Ito K; Okawa M
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):483-91. PubMed ID: 16904838
[TBL] [Abstract][Full Text] [Related]
7. Radiation pneumonitis following multi-field radiation therapy.
Tada T; Minakuchi K; Matsui K; Kawase I; Fukuda H; Nakajima T
Radiat Med; 2000; 18(1):59-61. PubMed ID: 10852657
[TBL] [Abstract][Full Text] [Related]
8. Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer.
Roelofs E; Engelsman M; Rasch C; Persoon L; Qamhiyeh S; de Ruysscher D; Verhaegen F; Pijls-Johannesma M; Lambin P;
J Thorac Oncol; 2012 Jan; 7(1):165-76. PubMed ID: 22071782
[TBL] [Abstract][Full Text] [Related]
9. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
[TBL] [Abstract][Full Text] [Related]
10. Effects of proton and combined proton/photon beam radiation on pulmonary function in patients with resectable but medically inoperable non-small cell lung cancer.
Bonnet RB; Bush D; Cheek GA; Slater JD; Panossian D; Franke C; Slater JM
Chest; 2001 Dec; 120(6):1803-10. PubMed ID: 11742905
[TBL] [Abstract][Full Text] [Related]
11. [Radiation pneumonitis and pulmonary fibrosis after the CT-planned radiotherapy of bronchial carcinoma].
Müller G; Kiricuta IC; Stiess J; Bohndorf W
Strahlenther Onkol; 1994 Jul; 170(7):400-7. PubMed ID: 8052939
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors of late radiation fibrosis: a prospective study in non-small cell lung cancer.
Mazeron R; Etienne-Mastroianni B; Pérol D; Arpin D; Vincent M; Falchero L; Martel-Lafay I; Carrie C; Claude L
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):38-43. PubMed ID: 20171801
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of whether radiation pneumonitis is influenced by low-dose irradiated lung volume in primary lung cancer with chronic pulmonary disease.
Niibe Y; Hayakawa K; Masuda N; Yoshimura H
Gan To Kagaku Ryoho; 2007 Feb; 34(2):213-6. PubMed ID: 17301529
[TBL] [Abstract][Full Text] [Related]
14. Comparison of dose-volume histograms between proton beam and X-ray conformal radiotherapy for locally advanced non-small-cell lung cancer.
Ohno T; Oshiro Y; Mizumoto M; Numajiri H; Ishikawa H; Okumura T; Terunuma T; Sakae T; Sakurai H
J Radiat Res; 2015 Jan; 56(1):128-33. PubMed ID: 25368341
[TBL] [Abstract][Full Text] [Related]
15. Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer.
Sejpal S; Komaki R; Tsao A; Chang JY; Liao Z; Wei X; Allen PK; Lu C; Gillin M; Cox JD
Cancer; 2011 Jul; 117(13):3004-13. PubMed ID: 21264827
[TBL] [Abstract][Full Text] [Related]
16. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
[TBL] [Abstract][Full Text] [Related]
17. [Application of standardized uptake value for FDG PET-CT in predicting radiation pneumonitis].
Zhang Y; Yu YH; Yu JM; He W; Fu Z; Guo SF; Liu XJ; Cong CS
Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):622-5. PubMed ID: 20021952
[TBL] [Abstract][Full Text] [Related]
18. Radiation pneumonitis complicating mediastinal radiotherapy postpneumonectomy.
Shulimzon T; Apter S; Weitzen R; Yellin A; Brenner HJ; Wollner A
Eur Respir J; 1996 Dec; 9(12):2697-9. PubMed ID: 8980989
[TBL] [Abstract][Full Text] [Related]
19. [Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Cancer Radiother; 2005 Sep; 9(5):304-15. PubMed ID: 16087377
[TBL] [Abstract][Full Text] [Related]
20. Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study.
Nichols RC; Huh SN; Henderson RH; Mendenhall NP; Flampouri S; Li Z; D'Agostino HJ; Cury JD; Pham DC; Hoppe BS
Clin Lung Cancer; 2011 Jul; 12(4):252-7. PubMed ID: 21726825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
